製品名:6-oxospiro[3.3]heptane-2-carboxylic acid

IUPAC Name:6-oxospiro[3.3]heptane-2-carboxylic acid

CAS番号:889944-57-4
分子式:C8H10O3
純度:97%
カタログ番号:CM104230
分子量:154.17

包装単位 有効在庫 価格(USD) 数量
CM104230-5g in stock ŸŞdž
CM104230-10g in stock Ɛƴƚ
CM104230-25g in stock ŪŪdž

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:889944-57-4
分子式:C8H10O3
融点:-
SMILESコード:OC(=O)C1CC2(C1)CC(=O)C2
密度:
カタログ番号:CM104230
分子量:154.17
沸点:
MDL番号:MFCD08436470
保管方法:

Category Infos

Spiro Compounds
A spiro compound is a polycyclic compound in which two monocyclic rings share one carbon atom; the shared carbon atom is called a spiro atom. Spiro compounds have rigid structures, stable structures, and have special properties that general organic compounds do not possess, such as anomeric effect, spiro conjugation and spiro hyperconjugation. Compared with the monocyclic structure or the planar aromatic structure, the spiro structure has a larger three-dimensional structure; the heterocyclic spiro structure is also regarded as the biological isostere of some groups, which can change the drug to a certain extent. The water solubility, lipophilicity, dominant conformation and ADMET properties of the molecule make the optimized lead molecule easier to drug. Therefore, spiro compounds occupy a very important position in drug development.
Spiro And Bicyclic Compound
Hot sale various high quality spiro and bicyclic compound from china leading manufacturer. Our products are efficient, cost effective and deliver more benefits. welcome to choose us!
Cyclobutanes
The molecular structure of cyclobutane has four carbon atoms, and its four carbon atoms are not in the same plane, which is the folded conformation of cyclobutane. Cyclobutane itself is not of commercial or biological interest, but more complex derivatives are important in biology and biotechnology. Currently, nine FDA-approved drugs contain the cyclobutane structure. From the perspective of therapeutic areas, cyclobutyl drugs are mainly distributed in popular areas such as tumors, neurological diseases, infectious diseases, endocrine and metabolic diseases.

Column Infos